BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arguedas MR. Screening for hepatocellular carcinoma: Why, when, how? Curr Gastroenterol Rep 2003;5:57-62. [DOI: 10.1007/s11894-003-0010-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Guiu B, Loffroy R, Ben Salem D, Lepage C, Guiu S, Aho S, Jouve JL, Krausé D, Cercueil JP. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma. Abdom Imaging 2008;33:520-8. [PMID: 17912584 DOI: 10.1007/s00261-007-9327-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]